| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.53 | 0.008 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |